Hemolysis: A harbinger of adverse outcome after left ventricular assist device implant

Journal of Heart and Lung Transplantation

Volumn 33, Issue 1, 2014, Pages 35-43

  Cowger, Jennifer A ^a   Romano, Matthew A ^a   Shah, Palak ^a   Shah, Neha ^a   Mehta, Vivek ^a   Haft, Jonathan W ^a   Aaronson, Keith D ^a   Pagani, Francis D ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Hemolysis; Lactate dehydrogenase; Left ventricular assist device; Serum free hemoglobin

Indexed keywords

ACETYLSALICYLIC ACID; APROTININ; DIPYRIDAMOLE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN; HEPARIN; LACTATE DEHYDROGENASE; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; WARFARIN;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; DRUG DOSE INCREASE; EMBOLISM; EVENT FREE SURVIVAL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MIDDLE AGED; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; THROMBOSIS;

HEMOLYSIS; LACTATE DEHYDROGENASE; LEFT VENTRICULAR ASSIST DEVICE; SERUM FREE HEMOGLOBIN;

ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HEMOGLOBINS; HEMOLYSIS; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBOSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84892185289     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2013.08.021     Document Type: Article

References (6)

1. M.S. Slaughter, J.G. Rogers, and C.A. Milano et al. Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
2. F.D. Pagani, L.W. Miller, and S.D. Russell et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device J Am Coll Cardiol 54 2009 312 321
3. Interagency Registry for Mechanically Assisted Circulatory Support, National Heart Lung and Blood Institute. Exhibit 21b: Adverse event rates for patients receiving a primary prospective continuous-flow LVAD. Contract Award HHSN268201100025C. Available at: http://www.uab.edu/medicine/intermacs/images/ Federal-Quarterly-Report/Statistical-Summaries/Federal-Partners-Report-2012-Q3. pdf. Accessed December 12, 2012.
4. Interagency Registry for Mechanically Assisted Circulatory Support, National Heart Lung and Blood Institute. Adverse event definitions. Contract Award HHSN268201100025C. Available at: http://www.uab.edu/medicine/intermacs/ manual-of-operations/manual-of-operations-dropdown3/appendix-a-adverse-event- definitions. Accessed December 12, 2013.
5. P. Shah, V.M. Mehta, and J.A. Cowger et al. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support J Heart Lung Transplant 33 2014 102 104
6. J.A. Hanley, and B.J. McNeil A method of comparing the areas under the receiver operating characteristic curves derived from the same cases Radiology 148 1983 839 843